Clinical Trial Update: Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection [Phase 2]

View source ↗

Summary

Phase 2 safety study of fluconazole plus flucytosine for disseminated cryptococcal infection was terminated; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Infection

Drugs mentioned

• Fluconazole (Fluconazole)
• Flucytosine (flucytosine)

Snippet

Sponsor: Yale University | Conditions: Cryptococcal Infection Disseminated | Phase 2 | Status: TERMINATED | Results posted: 2015-08-31